Related Experiment Video
Updated: Oct 24, 2026

Enhanced Cochlear Coverage and Hearing Preservation in High-Frequency Hearing Loss via Electric Acoustic Stimulation with Longer Electrode
Published on: October 11, 2024
Prescriptions; requirements clarification--Drug Enforcement Administration (DEA). Final rule
Abstract:
This final rule amends 21 CFR 1306.05 and 1306.13 to clarify the requirements of prescriptions for controlled substances, and to extend the partial filling of Schedule II prescriptions to patients in hospice or home-care that have a medical diagnosis documenting a terminal illness. The proposal regarding the use of medication order sheets for filling prescriptions for patients in Long Term Care Facilities under the provisions of 21 CFR 1306.11 is not adopted at this time and will be the subject of a separate proposed Federal Register announcement which will allow a period for additional comments.
Related Concept Videos
Drug Regulation
FDA Approved Drugs: Changes to Approved Drugs
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Dosage Regimens: Designs and Approaches
Drug Control Governance: Regulatory Bodies and Their Impact
